Abstract
Purpose
To explore patients’ willingness to have medication adherence measured using different methods and evaluate the feasibility and validity of their combination (i.e., pill counts, a medication diary and a questionnaire assessing adherence two months post-discharge).
Methods
(1) A cross-sectional evaluation of the willingness of patients with polypharmacy to have their medication adherence measured post-discharge. (2) Medication adherence was monitored during two months using pill counts based on preserved medication packages and a diary in which patients registered their adherence-related problems. During a home visit, the Probabilistic Medication Adherence Scale (ProMAS) and a questionnaire on feasibility were administered.
Results
A total of 144 participants completed the questionnaire at discharge. The majority was willing to communicate truthfully about their adherence (97%) and to share adherence-related information with healthcare providers (99%). More participants were willing to preserve medication packages (76%) than to complete a medication diary (67%) during two months. Most participants reported that preserving medication packages (91%), completing the diary (99%) and the ProMAS (99%) were no effort to them. According to the majority of participants (60%), pill counts most accurately reflected medication adherence, followed by the diary (39%) and ProMAS (1%). Medication adherence measured by pill counts correlated significantly with ProMAS scores, but not with the number of diary-reported problems. However, adherence measured by the medication diary and ProMAS correlated significantly.
Conclusion
Combining tools for measuring adherence seems feasible and can provide insight into the accordance of patients’ actual medication use with their prescribed regimen, but also into problems contributing to non-adherence.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Vrijens B et al (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73(5):691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x
Sabate E (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva, Switzerland
Masnoon N et al (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17(1):230. https://doi.org/10.1186/s12877-017-0621-2
Kardas P, Lewek P, Matyjaszczyk M (2013) Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 4:91. https://doi.org/10.3389/fphar.2013.00091
Marcum ZA, Gellad WF (2012) Medication adherence to multidrug regimens. Clin Geriatr Med 28(2):287–300. https://doi.org/10.1016/j.cger.2012.01.008
Hovstadius B, Petersson G (2012) Factors leading to excessive polypharmacy. Clin Geriatr Med 28(2):159–172. https://doi.org/10.1016/j.cger.2012.01.001
Zelko E, Klemenc-Ketis Z, Tusek-Bunc K (2016) Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Materia socio-medica 28(2):129–132. https://doi.org/10.5455/msm.2016.28.129-132
Cutler RL et al (2018) Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open 8(1):e016982. https://doi.org/10.1136/bmjopen-2017-016982
De Vera MA et al (2014) Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol 78(4):684–698. https://doi.org/10.1111/bcp.12339
Iuga AO, McGuire MJ (2014) Adherence and health care costs. Risk Manage Healthc Policy 7:35–44. https://doi.org/10.2147/RMHP.S19801
Simpson SH et al (2006) A meta-analysis of the association between adherence to drug therapy and mortality BMJ (Clinical research ed.), 333(7557): p. 15–15 https://doi.org/10.1136/bmj.38875.675486.55
van Boven JF et al (2014) Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med 108(1):103–113. https://doi.org/10.1016/j.rmed.2013.08.044
Anderson LJ et al (2020) A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health-System Pharm 77(2):138–147. https://doi.org/10.1093/ajhp/zxz284
Cross AJ et al (2020) Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications Cochrane Database Syst Rev, 5(5): p. Cd012419 https://doi.org/10.1002/14651858.CD012419.pub2
Verloo H et al (2017) Nurse interventions to improve medication adherence among discharged older adults: a systematic review. Age Ageing 46(5):747–754. https://doi.org/10.1093/ageing/afx076
Presley B, Groot W, Pavlova M (2019) Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Res Social Adm Pharm 15(9):1057–1067. https://doi.org/10.1016/j.sapharm.2018.09.021
Anghel LA, Farcas AM, Oprean RN (2019) An overview of the common methods used to measure treatment adherence. Med Pharm Rep 92(2):117–122. https://doi.org/10.15386/mpr-1201
Lam WY, Fresco P (2015) Medication Adherence Measures: An Overview BioMed research international, 2015. : p. 217047–217047 https://doi.org/10.1155/2015/217047
Basu S et al (2019) Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Ci Ji Yi Xue Za Zhi 31(2):73–80. https://doi.org/10.4103/tcmj.tcmj_177_18
Pednekar PP et al (2019) Methods for measuring multiple medication adherence: a systematic review-report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value Health 22(2):139–156. https://doi.org/10.1016/j.jval.2018.08.006
Grymonpre RE et al (1998) Pill Count, Self-Report, and Pharmacy Claims Data to measure Medication Adherence in the Elderly. Ann Pharmacother 32(7–8):749–754. https://doi.org/10.1345/aph.17423
Elm JJ et al (2007) Self-reported adherence versus pill count in Parkinson’s disease: the NET-PD experience. Mov Disord 22(6):822–827. https://doi.org/10.1002/mds.21409
Wu P et al (2014) The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa. Curr HIV Res 12(5):366–375. https://doi.org/10.2174/1570162x1205141121102501
van Onzenoort HAW et al (2010) Assessing Medication Adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens 23(2):149–154. https://doi.org/10.1038/ajh.2009.207
El Alili M et al (2016) A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol 82(1):268–279. https://doi.org/10.1111/bcp.12942
Kleppe M et al (2015) The development of the ProMAS: a probabilistic medication adherence scale. Patient Prefer Adherence 9:355–367. https://doi.org/10.2147/PPA.S76749
Kleppe M (2016) Understanding medication adherence: a self-report measure and a dual-process framework
Mortelmans L, Dilles T (2024) The development and evaluation of a medication diary to report problems with medication use. Heliyon e26127. https://doi.org/10.1016/j.heliyon.2024.e26127
Liu XS, Carlson R, Kelley K (2019) Common language effect size for correlations. J Gen Psychol 146(3):325–338. https://doi.org/10.1080/00221309.2019.1585321
Rea F et al (2020) Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study. J Hypertens 38(1):142–149. https://doi.org/10.1097/hjh.0000000000002222
Chen SL et al (2014) Factors associated with gender differences in medication adherence: a longitudinal study. J Adv Nurs 70(9):2031–2040. https://doi.org/10.1111/jan.12361
Rebić N et al (2023) What’s sex and gender got to Do with it? A scoping review of sex- and gender-based analysis in Pharmacoepidemiologic studies of Medication Adherence. Value Health 26(9):1413–1424. https://doi.org/10.1016/j.jval.2023.04.002
Radic J et al (2023) Medication adherence and aender difference in hypertensive patients. J Hypertens, 41(Suppl 3).
Franchi C et al (2022) Multiple medication adherence and related outcomes in Community-Dwelling Older people on chronic polypharmacy: a retrospective cohort study on administrative Claims Data. Int J Environ Res Public Health 19(9):5692
Haynes RB et al (1980) Can simple clinical measurements detect patient noncompliance? Hypertension 2(6):757–764. https://doi.org/10.1161/01.hyp.2.6.757
Kleinsinger F (2018) The Unmet Challenge of Medication Nonadherence. Perm J 22:p18–033. https://doi.org/10.7812/tpp/18-033
Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clin Proc 86(4):304–314. https://doi.org/10.4065/mcp.2010.0575
Baumgartner PC et al (2018) A systematic review of Medication Adherence Thresholds Dependent of Clinical outcomes. Front Pharmacol 9. https://doi.org/10.3389/fphar.2018.01290
Pednekar P et al (2017) Measuring multiple medication adherence–which measure when? Value & Outcomes Spotlight, pp 17–20
Stirratt MJ et al (2015) Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med 5(4):470–482. https://doi.org/10.1007/s13142-015-0315-2
Wagner G, Miller LG (2004) Is the influence of social desirability on patients’ self-reported adherence overrated? J Acquir Immune Defic Syndr 35(2):203–204. https://doi.org/10.1097/00126334-200402010-00016
Culig J, Leppée M (2014) From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol 38(1):55–62
Lehmann A et al (2014) Assessing medication adherence: options to consider. Int J Clin Pharm 36(1):55–69. https://doi.org/10.1007/s11096-013-9865-x
Funding
L.M. was supported by the Research Foundation Flanders through grant 11L0522N. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Conceptualization, L.M., E.G., M.D.G., J.V.D., AM.D.C. , M.P., P.v.d.B and T.D.; Methodology, L.M., E.G., M.D.G., J.V.D., AM.D.C. , M.P., P.v.d.B and T.D.; Funding acquisition: L.M.; Formal analysis; L.M., Writing—Original Draft, L.M., Writing—Review and Editing, L.M., E.G., M.D.G., J.V.D., AM.D.C. , M.P., P.v.d.B and T.D. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mortelmans, L., Goossens, E., De Graef, M. et al. Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective. Eur J Clin Pharmacol 80, 891–900 (2024). https://doi.org/10.1007/s00228-024-03661-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-024-03661-1